Page 6 | Certara

Press Coverage Video

How FDA’s Focus on Overall Survival Redefines Trial Success

Ananth Kadambi explains how FDA’s emphasis on overall survival reshapes oncology drug trial success metrics…

CertaraSeptember 23, 2025

Conference

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

CertaraSeptember 22, 2025

Webinar

Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings

Danielle PillsburySeptember 22, 2025

Press Coverage Video

Operational Challenges of Using Overall Survival as a Primary Endpoint

In this ACT interview, Certara’s Ananth Kadambi discusses the operational hurdles sponsors face as FDA…

CertaraSeptember 22, 2025

On-Demand Webinar

Avoiding the MedChem Mutiny

CertaraSeptember 22, 2025

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

CertaraSeptember 22, 2025

Fact Sheet

Drug Interaction Database (DIDB ®)

Optimize DDI knowledge throughout drug development

CertaraSeptember 19, 2025

Blog

Best Practices in Clinical Pharmacology Gap Analysis

September 19, 2025 Submitting your New Drug Application (NDA) to the FDA is the ultimate…

CertaraSeptember 19, 2025

Announcement

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights,…

CertaraSeptember 17, 2025

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraSeptember 17, 2025

How FDA’s Focus on Overall Survival Redefines Trial Success

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings

Operational Challenges of Using Overall Survival as a Primary Endpoint

Avoiding the MedChem Mutiny

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Drug Interaction Database (DIDB ®)

Best Practices in Clinical Pharmacology Gap Analysis

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

Newsletter sign up

Quick links

Solutions

Contact